The Safety and Efficacy of Dapagliflozin Therapy in Combination With Insulin in Japanese Subjects With T1DM
Clinical trial NCT02582814 · COMPLETED
Trial details
- NCT number
- NCT02582814
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-26
- Primary completion
- 2017-06-15
- Enrollment
- 151
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.